Reducing Hospital Length of Stay and Hepatic Artery Thrombosis Rates for Children Receiving a Liver Transplant: A Single‐Center Experience From 2000 to 2021

Jack Fennessy,Gordon Thomas,Greer Waters,Michael Stormon,Albert Shun,Elena Cavazzoni
DOI: https://doi.org/10.1111/petr.14844
2024-08-18
Pediatric Transplantation
Abstract:A new anticoagulation protocol has helped reduce hepatic artery thrombosis rates and hospital length of stay in pediatric liver transplant recipients. To achieve better outcomes, recent emphasis has been placed on early extubation, and increased use of split liver grafts, which has successfully expanded the donor pool. Background Pediatric liver transplantation is a very resource‐intensive therapy. This study aimed to identify the changes made between two epochs of management and analyze their influence on length of stay (LOS). Methods Data from a single center were obtained from the liver transplant and Pediatric Intensive Care Unit (PICU) databases for 336 transplants (282 children) performed between 2000 and 2021. Transplants were analyzed in two epochs, before and after July 2012, representing a change in postoperative anticoagulation management. Differences in graft recipient demographics and perioperative management factors were compared between epochs. Multivariate regression was performed to identify the complications that correlated most strongly with hospital LOS. Results There was a difference in hospital LOS between Epoch 1 (Median = 31.7 days) and Epoch 2 (Median = 26.3 days) (p
pediatrics,transplantation
What problem does this paper attempt to address?